11 research outputs found
Omaha Trade Area Study No. 06: License Plate Survey of Five Major Shopping Points
This is the third of a series of continuing studies in the attempt to ascertain Omaha\u27s retail trade area. The method utilized, as in the past, is that of recording license plate prefix numbers at the three major and two minor shopping points within the Omaha SMSA. Emphasis is placed upon the three major shopping points, Downtown, Crossroads and Westroads, for they are the best indicators of the regional focus of Omaha. The two other points surveyed were Southroads and Downtown Council Bluffs (See Map 13, Page 5). This year the survey eliminated The Center, GEM and Skagway because of their community influence
Geographic Background Report No. 01: Omaha\u27s Agricultural Core Region
One of the critical problems in the delineation of the Omaha Trade Area to be solved by the geographer is the selection of the agricultural hinterland of Omaha. A series of maps, based on the 1959 and 1964 Census of Agriculture reports were developed. These basic maps were correlated with known data concerning agricultural shipments to the Omaha market. The result was the definition of an agricultural core region centered on Omaha
Omaha Trade Area Study No. 01: License Plate Survey of Two Major Shopping Points
This study is a preliminary attempt at the delimitation of Omaha\u27s retail trade area. The method used is that of recording license plate numbers at the two major shopping points in Omaha, the Central Business District and Crossroads, plus two other smaller shopping points--Southroads and The Center. Emphasis is placed upon the two major points for they give the best regional cross-section of Omaha\u27s retail attraction
Omaha Trade Area Study No. 04: Milk, Grain and Livestock Source Area
The milk marketing area of Omaha, shown on Figure 1, includes all or parts of 12 Nebraska counties and 20 counties in western Iowa. Normally 80 percent of Omaha\u27s fluid milk needs comes from the region outlined as Omaha\u27s milk marketing area. Southwest of Omaha, the major milk producing counties of Gage, Jefferson and Lancaster are part of the Lincoln milk marketing area. And to the northwest of Omaha are some of the heaviest bulk-milk producers i.e., milk used for manufactural purposes--dry milk products, etc. Therefore, even though Wayne, Pierce, Antelope and Cedar counties are the major milk producers in Nebraska, they are not included in the Omaha milkshed. Likewise, the major milk producing counties in western Iowa are part of the Sioux City milkshed
Omaha Trade Area Study No. 02: An Analysis of Telephone Calls, Newspaper Circulation, and Correspondent Banks
There are many limitations and statistical uncertainties in making a full interpretation of the Omaha Trade Area, but we plan to go as far as we can to bring together the commonly used indicators that show the sphere of influence of a major trade center. A number of indicators, such as retail sales, newspaper circulation, correspondent banks, grain shipments, etc., will be mapped individually. Then, for the final analysis, a composite map will be constructed to show the area of overall dominance by Omaha
Omaha Trade Area Study No. 05: Omaha Spheres of Influence
In nearly all cases, a city represents the focal point of a large area which it dominates. As distance away from the city increases the influence of the city decreases until a point is reached where another city of similar size exerts more influence. The purpose of this study is to establish and discuss the major area of dominance for Omaha
Recommended from our members
A comparison of land use in three Arizona communities
This item was digitized from a paper original and/or a microfilm copy. If you need higher-resolution images for any content in this item, please contact us at [email protected]
Recommended from our members
Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS
Background and Purpose: Although most strokes present with mild symptoms, these have been poorly represented in clinical trials. The objective of this study is to describe multidimensional outcomes, identify predictors of worse outcomes, and explore the effect of thrombolysis in this population. Methods: This prospective observational study included patients with ischemic stroke or transient ischemic attack, a baseline National Institutes of Health Stroke Scale (NIHSS) score 0 to 5, presenting within 4.5 hours from symptom onset. The primary outcome was a 90-day modified Rankin Scale score of 0 to 1; secondary outcomes included good outcomes in the Barthel Index, Stroke Impact Scale-16, and European Quality of Life. Multivariable models were created to determine predictors of outcomes and the effect of alteplase. Results: A total of 1765 participants were included from 100 Get With The Guidelines-Stroke participating hospitals (age, 65±14; 42% women; final diagnosis of ischemic stroke, 90%; transient ischemic attack, 10%; 57% received alteplase). At 90 days, 37% were disabled and 25% not independent. Worse outcomes were noted for older individuals, women, non-Hispanic Blacks and Hispanics, Medicaid recipients, smokers, those with diabetes, atrial fibrillation, prior stroke, higher baseline NIHSS, visual field defects, and extremity weakness. Similar outcomes were noted for the alteplase-treated and untreated groups. Alteplase-treated patients were younger (64±13 versus 67±1.4) with higher NIHSS (2.9±1.4 versus 1.7±1.4). After adjusting for age, sex, race/ethnicity, and baseline NIHSS, we did not identify an effect of alteplase on the primary outcome but did find an association with Stroke Impact Scale-16 in the restricted sample of baseline NIHSS score 3–5. Few symptomatic intracerebral hemorrhages were recorded (<1%). Conclusions: A large proportion of stroke patients presenting with low NIHSS have a disabled outcome. Baseline predictors of worse outcomes are described. An effect of alteplase on outcomes was not identified in the overall cohort, but a suggestion of efficacy was noted in the NIHSS 3–5 subgroup. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02072681